Elekta gaining hydrocephalus product line with $14.8 mil. Cordis Neuroscience buy.
This article was originally published in The Gray Sheet
Executive Summary
ELEKTA'S $14.8 MIL. ACQUISITION OF CORDIS NEUROSCIENCE gives the Stockholm, Sweden-based firm a line of hydrocephalus management products to add to its neurosurgery offerings. Elekta announced Dec. 5 an agreement to acquire the Cordis Neuroscience business from Johnson & Johnson. The deal, contingent upon approval by the U.S. Federal Trade Commission, is expected to close by February 1997.